ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2
申请人:Wong Yung Hou
公开号:US20100317691A1
公开(公告)日:2010-12-16
A method of treating, preventing, or ameliorating a pathological condition associated with a melatonin receptor in a mammal by using a pharmaceutical composition containing a compound of formula (I) as a ligand interacting with the melatonin receptor,
R
1
, R
2
, R
3
, R
4
and R
7
are independently H, halo, alkyloxyl, alkyl or hydroxyl, provided that one of R
1
, R
2
, R
3
and R
7
is X—(CH
2
)
n
—R
8
; R
5
is alkyl or arylalkyl; R
6
is H or alkyl; X is a bond, O, S, SO, SO
2
, CO or NH; n=
0
-
10
; R
8
is alkenyl, substituted or unsubstituted aryl, NR
9
R
10
, or OR
9
; R
9
is H, substituted or unsubstituted arylmethyl, or alkenyl; and R
10
is H or alkyl.
一种通过使用含有化合物(I)作为与褪黑激素受体相互作用的配体的药物组合物来治疗、预防或改善与哺乳动物中褪黑激素受体相关的病理状况的方法,其中R1、R2、R3、R4和R7独立地为H、卤素、烷氧基、烷基或羟基,前提是R1、R2、R3和R7中的一个是X—(CH2)n—R8;R5为烷基或芳基烷基;R6为H或烷基;X为键、O、S、SO、SO2、CO或NH;n=0-10;R8为烯烃基、取代或未取代的芳基、NR9R10或OR9;R9为H、取代或未取代的芳基甲基或烯烃基;R10为H或烷基。